Anti-Infective Drugs Advisory Committee; Notice of Meeting – TMCnet

On April 4, 2012, the committee will discuss the data provided to support the safety and efficacy of levofloxacin for the treatment of pneumonic plague in humans. Johnson and Johnson Pharmaceutical Research and Development, LLC (on behalf of …

Leave a Reply

Your email address will not be published.

*